ATHENS, Texas, Nov. 16, 2010 /PRNewswire/ — Argon Medical
Devices, Inc. announced today that it has entered into a definitive
licensing agreement with Rex Medical, LP (“Rex Medical”) for
exclusive rights to market and distribute the UltraStream chronic
dialysis catheter ™ on a global basis.
UltraStream™ is designed to provide long-term vascular
access to patients receiving dialysis treatments.
Argon will be exhibiting at the 37th Veithsymposium™ to be
held in New York City from November 17-21, 2010.
“The addition of UltraStream™ reinforces our commitment to
providing physicians with innovative products focused on improving
patient care,” said George A. Leondis, President of Argon Medical
Devices, Inc. “We are excited about this opportunity to further
enhance our portfolio of products for use in the area of dialysis
access, which also includes the Cleaner™ Rotational
Thrombectomy System.”
There are over 500,000 patients currently undergoing treatment
in the U.S. for End-Stage Renal Disease (ESRD). It is estimated
that the dialysis patient population will continue to grow at a
rate exceeding 6% annually.
About Argon
Argon Medical Devices, Inc., based in Athens, TX, is a
privately-held global medical device company which manufactures and
markets solutions for cardiovascular, venous access and critical
care procedures. It is a portfolio company of Roundtable Healthcare
Partners.
About Roundtable
RoundTable Healthcare Partners, based in Lake Forest, IL, is an
operating-oriented private equity firm focused exclusively on the
health-care industry. The partners of RoundTable have significant
experience in managing, operating, acquiring and financing
multibillion-dollar diversified health-care companies. RoundTable
partners with companies that can benefit from its extensive
industry relationships and proven operating and transaction
expertise.
About Rex Medical
‘/>”/>
